Man Group plc Invests $2.92 Million in Corteva, Inc. $CTVA

Man Group plc bought a new stake in Corteva, Inc. (NYSE:CTVA) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 34,527 shares of the company’s stock, valued at approximately $2,924,000.

Other large investors have also bought and sold shares of the company. BlackRock Inc. acquired a new position in Corteva during the 2nd quarter worth about $4,560,180,000. Harris Associates L P raised its stake in shares of Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after acquiring an additional 10,675,052 shares during the last quarter. Norges Bank bought a new position in shares of Corteva in the fourth quarter worth about $504,001,000. Jupiter Topco LLC acquired a new position in shares of Corteva during the second quarter worth approximately $544,246,000. Finally, Legal & General Group Plc bought a new stake in shares of Corteva during the second quarter valued at approximately $482,836,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Performance

Shares of CTVA stock opened at $84.74 on Tuesday. The stock has a market cap of $56.54 billion, a PE ratio of 56.12, a price-to-earnings-growth ratio of 2.58 and a beta of 0.57. The stock has a 50-day moving average of $82.81 and a 200-day moving average of $80.66. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same quarter last year, the firm earned $2.20 EPS. Corteva’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, sell-side analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s payout ratio is 47.68%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $101.00 price objective on shares of Corteva in a report on Monday, August 3rd. UBS Group cut their price target on Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 18th. Citigroup raised their price target on Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a report on Monday, August 3rd. Morgan Stanley boosted their price objective on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Finally, Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.